MPO is also highly expressed in certain cancers, such as colon adenocarcinoma, pancreatic adenocarcinoma, and acute myeloid leukemia, as inferred from the TIMER2 database (Figure 1C). Here, MPO is linked to pancreatic adenocarcinoma.